Decibel Cannabis Q4 FY25 Update – DB.v/ DBCCF

Decibel Cannabis Q4 FY25 Update – DB.v/ DBCCF

Petty Cash
Petty CashApr 17, 2026

Key Takeaways

  • Q4 revenue rose 13% YoY to CAD 28.7M ($21M USD).
  • International sales surged 116% YoY, now 27% of total revenue.
  • Adjusted EBITDA hit CAD 6.2M, margin 21‑23% projected for 2026.
  • Debt leverage stays under 2.5x after Creston sale and ATB facility extension.
  • Share price ~CAD0.14; potential consolidation could lift it above CAD1.

Pulse Analysis

Decibel Cannabis (DB) continues to differentiate itself in a crowded Canadian market by leveraging a dual‑track growth strategy that blends domestic product innovation with aggressive international expansion. The company’s Q4 FY25 results show a 13% revenue lift to CAD 28.7 million, driven largely by a 116% surge in EU‑GMP export sales to Germany and the UK. This international momentum now accounts for roughly a quarter of total revenue, offsetting a modest 3% dip in Canadian sales caused by a temporary labor strike in British Columbia. By focusing on high‑margin infused pre‑rolls and vape products at home, while exporting premium flower and extracts abroad, Decibel is building a diversified revenue base that can weather regional regulatory swings.

Financially, Decibel posted adjusted EBITDA of CAD 6.2 million, a 19% YoY increase, and projects an EBITDA margin of 21‑23% for 2026. The firm’s capital plan emphasizes minimal capex, relying on operating cash flow, a refreshed ATB credit facility, and proceeds from the CAD 2.5 million Creston facility sale to fund automation and capacity upgrades. These measures, combined with a projected leverage ratio below 2.5×, suggest a solid balance sheet that can support further expansion without excessive debt. The company’s ability to double processing capacity from 60 to 120 tons per annum with limited investment underscores its operational leverage.

Looking ahead, catalysts such as a potential share consolidation that could push the price above CAD 1 and continued deleveraging are likely to attract valuation‑focused investors. At roughly 4.7× EV/EBITDA and under 10× EV/FCF, Decibel trades at a discount to peers, offering upside if international margins improve and domestic market share gains materialize. The firm’s strategic focus on automation, extraction scale‑up, and expanding EU‑GMP capabilities positions it well to capture growth in both the Canadian and global cannabis landscapes.

Decibel Cannabis Q4 FY25 Update – DB.v/ DBCCF

Comments

Want to join the conversation?